NCT07246603 Virtual Housecalls: Redesigning Pediatric Primary Care Adolescent Obesity Treatment
| NCT ID | NCT07246603 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Virginia Commonwealth University |
| Condition | Class I Obesity |
| Study Type | INTERVENTIONAL |
| Enrollment | 500 participants |
| Start Date | 2026-08-25 |
| Primary Completion | 2029-07-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 500 participants in total. It began in 2026-08-25 with a primary completion date of 2029-07-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This pragmatic randomized clinical trial tests a novel intensive health behavior and lifestyle intervention, conducted via telehealth, to treat class I adolescent obesity in pediatric primary care. Results will inform scalable approaches that meet the recommended treatment dose and effectively treat obesity in this setting.
Eligibility Criteria
Adolescent Inclusion Criteria: * English or Spanish-speaking * 12-15 years of age * Receiving care at a participating clinic * Body Mass Index (BMI) ≥95% and \<120% of the 95% * Access to a mobile device with a webcam that can receive texts Parent Inclusion Criteria: * English or Spanish-speaking * Primary legal guardian ≥18 years of age living with the adolescent Exclusion Criteria: * conflicts that would inhibit the ability to participate in all aspects of the study as outlined in the study protocol * family plans to move outside of the study area or plans to no longer be a patient at a participating clinic in the 12 month study period * the primary care provider or PI determines that the study is not clinically or medically appropriate (e.g., significant psychiatric, cognitive, physical or developmental conditions that would impair their ability to complete assessments, participate in study sessions, or conduct physical activity) based on screening at study onset * adolescent exhibits severe dietary restriction or compensatory behavior (e.g., vomiting, laxative abuse) based on screening at study onset and clinical interview by a study psychologist * adolescent is currently pregnant/plans to become pregnant during study period * adolescent is participating in another weight loss program, has had or plans to undergo weight loss surgery * adolescent has a chronic medical condition(s) and/or uses medication that substantially impacts or interferes with growth, appetite, weight or physical activity participation * adolescents taking anti-obesity medication are ineligible if they are not a stable dose for at least 3 months prior to study participation
Contact & Investigator
Melanie K Bean, PhD
PRINCIPAL INVESTIGATOR
Virginia Commonwealth University
Frequently Asked Questions
Who can join the NCT07246603 clinical trial?
This trial is open to participants of all sexes, aged 12 Years or older, up to 15 Years, studying Class I Obesity. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07246603 currently recruiting?
Yes, NCT07246603 is actively recruiting participants. Contact the research team at sarah.malone@vcuhealth.org for enrollment information.
Where is the NCT07246603 trial being conducted?
This trial is being conducted at Henrico, United States.
Who is sponsoring the NCT07246603 clinical trial?
NCT07246603 is sponsored by Virginia Commonwealth University. The principal investigator is Melanie K Bean, PhD at Virginia Commonwealth University. The trial plans to enroll 500 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.